Products
Data Sets
Integrations
Services
FUNDRAISING NEWS | December 18, 2024
Tags: Private Equity, Venture Capital, Fundraising
Life sciences-focused venture capital firm XGEN Venture secured €180M (~$188.5M) in capital commitments at the final close of its first life sciences fund.
XGEN Venture Life Sciences Fund generated pledges from institutional investors, family offices and high-net-worth individuals. It targets early-stage investments in biotechnology, medical devices and diagnostics.
The fund has so far invested in six startups including clinical-stage biopharmaceutical company iOnctura. Over the next two to three years, it intends to complete its portfolio, with nine more investments planned.
Written By: Dakota
VC Shift4Good Closes First Fund Above Target at €220M
January 27, 2025
Gaming and Digital Entertainment VC Transcend to Launch Third Seed Fund
January 21, 2025
Apollo-backed New Catalyst Plans Sale of A Shares in Debut Fund
January 21, 2025
VCFA Raises $122.5M for Venture Secondaries Fund VII, Makes Two Promotions
January 16, 2025
Seed-stage VC Root Ventures Targets $250M for Fourth Fund
January 14, 2025
925 West Lancaster Ave
Suite 220
Bryn Mawr, PA 19010
Tel: (610) 642-1481
© Dakota 2025 | Terms of Use | Privacy Policy
